about
sameAs
Molecular imaging in cardiovascular diseasesMagnetic resonance coronary angiography: where are we today?Advanced respiratory motion compensation for coronary MR angiographyIn vivo magnetic resonance imaging of experimental thrombosis in a rabbit modelIn vivo MR-angiography for the assessment of aortic aneurysms in an experimental mouse model on a clinical MRI scanner: Comparison with high-frequency ultrasound and histology.High-frequency speckle tracking echocardiography in the assessment of left ventricular function and remodeling after murine myocardial infarctionCoronary MR angiography using image-based respiratory motion compensation with inline correction and fixed gating efficiency.A self-normalization reconstruction technique for PET scans using the positron emission data.Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis.Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging.Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging.Coronary MR angiography: comparison of quantitative and qualitative data from four techniques.Highly efficient nonrigid motion-corrected 3D whole-heart coronary vessel wall imaging.Molecular imaging with targeted contrast agents.Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging.Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agentCoronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patientsCoronary magnetic resonance angiography.Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification.Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.Single breath-hold assessment of cardiac function using an accelerated 3D single breath-hold acquisition technique--comparison of an intravascular and extravascular contrast agent.Left-sided pulmonary venous pathway obstruction after Mustard operation.Coronary magnetic resonance imaging: current status.Coronary MR angiography clinical applications and potential for imaging coronary artery disease.Monitoring vascular permeability and remodeling after endothelial injury in a murine model using a magnetic resonance albumin-binding contrast agent.Coronary artery size and origin imaging in children: a comparative study of MRI and trans-thoracic echocardiography.Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration.Coronary MR angiography at 3T: fat suppression versus water-fat separationAssessment of Myocardial Remodeling Using an Elastin/Tropoelastin Specific Agent with High Field Magnetic Resonance Imaging (MRI)Cardiovascular magnetic resonance imaging of coronary atherothrombosis.MRI-based prediction of adverse cardiac remodeling after murine myocardial infarctionCoronary magnetic resonance imaging: current state-of-the-art.Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis.Bone marrow transplantation modulates tissue macrophage phenotype and enhances cardiac recovery after subsequent acute myocardial infarctionA bisphosphonate for (19)F-magnetic resonance imagingDetection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience.Protein kinase G oxidation is a major cause of injury during sepsis.Structural and functional imaging by MRI.
P50
Q26825112-23D5876E-ACA7-4878-BD77-2C7CF2946F55Q26825112-A7555341-20B9-466B-A583-6B4E04E1A024Q27003403-69CFFD61-043B-4B46-8C9C-F3FAFBAFC3C1Q27026674-5B4CA84B-EC49-4F08-9D05-DABFD5AE6288Q27026674-D946D49B-29ED-440C-9C93-64CB6923308BQ28353718-06563A16-BCCB-4334-BBBB-1A4CCC762252Q30354185-6A2385C9-9F0A-4E64-B65D-A815C968427CQ30354185-77DBCA5B-5746-4E00-A4A4-8763BEE4D61EQ30412867-3E9C61DD-0F2A-44AD-81B0-27D9AF73B4E1Q30412867-58561C7F-AD59-4561-BC01-4AD968528123Q30491182-6A0A6E4F-2545-40F8-967A-9761C2B44309Q30491182-C42C4DF1-8817-4145-AAF3-F41400923F6FQ30558601-2F1C7798-C13A-436B-86C8-766E7433A4E6Q30558601-F98132D6-585E-44D0-88B6-164579148EBCQ30575933-94C10D51-D9A0-4265-9D2F-E9BDCBF286BAQ30575933-9CEE7FB7-A4C2-4EF6-B9B5-8C7969F41A65Q30578977-C00FE17F-B2E6-4168-A2BB-54D0FE97FAEEQ30578977-FADFD711-9503-435C-B7BA-94DE34A251EBQ30831913-06B0B623-7A4D-40BA-976B-32B3257D0AD4Q30831913-0EC28617-A16B-4487-B34C-96F48C5C5190Q30889529-212AB1B6-510E-4661-8D34-06892B448D55Q33626159-8DE93772-16F3-4741-A1EB-A266DDD8654FQ33626159-987AF716-2045-4F48-9A32-9FAD9A006533Q33678679-89B5057B-84D4-44FC-BDA6-C84F293B1808Q33694895-3BBC4861-507B-4286-A75F-0007A5639F32Q33712037-06BE5FD8-9FB3-400F-B270-BF616B7DFC0FQ33712037-B0685AC8-8F64-4045-92DB-6312AF848E46Q33997638-CE70AB91-1895-4DE9-ABEA-B5D09CE779D7Q33997638-CEB946C0-3E05-4AA0-BFCE-D7A40A43B956Q34022293-4892DCC5-B9D3-489F-9BE0-F8C78B1026CFQ34061425-3849436E-BD08-4433-BF40-CE84417C6705Q34157231-E2F07EDB-8F6B-4237-8705-B68B65B2D246Q34206352-F4FF0A4D-B55E-4D4A-AB6D-179191258B1FQ34333548-456F9B68-9EED-4486-99AC-692C52F188B2Q34333548-645D6EDF-7605-4D2E-BF06-ED0BD33D5F0AQ34360350-6520400E-C8D0-4A3D-888A-5A1EBAB54E2AQ34360350-8EA97E3E-3460-4FF5-8C40-46542C0DA5CCQ34411246-B57B8EF7-4824-4BB5-B82B-6AE40BBB3977Q34793961-91935E08-D51E-4EB5-AC39-AEF4CE8DAAD5Q35149979-FA235FC6-FF4D-4C1A-98DF-0E891C4D3A77
P50
description
forsker
@nb
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
René M Botnar
@ast
René M Botnar
@nl
René M Botnar
@sl
René M. Botnar
@da
René M. Botnar
@de
René M. Botnar
@en
René M. Botnar
@es
René M. Botnar
@fr
René M. Botnar
@nb
René M. Botnar
@nn
type
label
René M Botnar
@ast
René M Botnar
@nl
René M Botnar
@sl
René M. Botnar
@da
René M. Botnar
@de
René M. Botnar
@en
René M. Botnar
@es
René M. Botnar
@fr
René M. Botnar
@nb
René M. Botnar
@nn
altLabel
René Botnar
@en
René M Botnar
@en
René Michael Botnar
@en
prefLabel
René M Botnar
@ast
René M Botnar
@nl
René M Botnar
@sl
René M. Botnar
@da
René M. Botnar
@de
René M. Botnar
@en
René M. Botnar
@es
René M. Botnar
@fr
René M. Botnar
@nb
René M. Botnar
@nn
P214
P1053
E-6875-2012
P106
P1153
35602500200
P21
P214
P31
P3829
P496
0000-0002-9447-4367
0000-0003-2811-2509
P735
P7859
viaf-35285163